<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Daunorubicin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Daunorubicin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Daunorubicin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Daunorubicin_files/filelist.xml">
<title>DAUNORUBICIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:04:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:22:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1341</o:Words>
  <o:Characters>7647</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>63</o:Lines>
  <o:Paragraphs>17</o:Paragraphs>
  <o:CharactersWithSpaces>8971</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>DAUNORUBICIN</span><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'><o:p></o:p></span></h1>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>(Daunomycin)<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>: Daunorubicin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC:</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> L01D
B02.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c:</span></b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'> Ch&#7889;ng ung th&#432;/Kháng sinh lo&#7841;i
anthracyclin glycosid.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7897;t
pha tiêm: 20 mg (dùng daunorubicin hydroclorid nh&#432;ng tính hàm l&#432;&#7907;ng
theo daunorubicin base).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7883;ch
&#273;&#7853;m &#273;&#7863;c &#7903; d&#7841;ng vi h&#7841;t lipid &#273;&#7875;
pha loãng truy&#7873;n t&#297;nh m&#7841;ch, ch&#7913;a m&#7897;t dung d&#7883;ch
n&#432;&#7899;c c&#7911;a daunorubicin citrat trong các túi lipid (vi h&#7841;t
lipid): L&#7885; ch&#7913;a 50 mg, tính theo daunorubicin base, &#7903; n&#7891;ng
&#273;&#7897; 2 mg/ml (tên th&#432;&#417;ng m&#7841;i: Daunoxome).<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
là m&#7897;t anthracyclin glycosid, thu&#7897;c lo&#7841;i kháng sinh
nh&#432;ng không dùng nh&#432; m&#7897;t thu&#7889;c kháng khu&#7849;n.
Daunorubicin có tác d&#7909;ng m&#7841;nh nh&#7845;t &#273;&#7871;n pha S trong
chu trình phân chia t&#7871; bào nh&#432;ng không &#273;&#7863;c hi&#7879;u
theo pha. C&#417; ch&#7871; ch&#7889;ng ung th&#432; c&#7911;a thu&#7889;c là g&#7855;n
k&#7871;t v&#7899;i DNA xen vào gi&#7919;a các c&#7863;p base và &#7913;c ch&#7871;
t&#7893;ng h&#7907;p DNA và RNA, làm r&#7889;i lo&#7841;n m&#7851;u sao chép và
ng&#259;n c&#7843;n phiên b&#7843;n. Do &#273;ó, tác d&#7909;ng ch&#7889;ng ung
th&#432; t&#7889;i &#273;a &#273;&#432;&#7907;c th&#7921;c hi&#7879;n &#7903;
pha t&#7893;ng h&#7907;p DNA (pha S) c&#7911;a chu trình phân bào. Ngoài ra thu&#7889;c
còn có tác d&#7909;ng kháng khu&#7849;n và &#7913;c ch&#7871; mi&#7877;n d&#7883;ch.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
&#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#432;&#7907;c phân b&#7889; nhanh vào trong c&#417; th&#7875;, &#273;&#7863;c
bi&#7879;t là th&#7853;n, lách, gan, và tim &#7903; d&#432;&#7899;i d&#7841;ng
ch&#432;a bi&#7871;n &#273;&#7893;i và d&#7841;ng chuy&#7875;n hóa, nh&#432;ng
thu&#7889;c không qua &#273;&#432;&#7907;c hàng rào máu - não. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Chuy&#7875;n
hóa sinh h&#7885;c &#7903; gan, x&#7843;y ra nhanh (trong vòng m&#7897;t gi&#7901;),
t&#7841;o thành m&#7897;t ch&#7845;t chuy&#7875;n hóa ch&#7911; y&#7871;u là
daunorubicinol có ho&#7841;t tính ch&#7889;ng ung th&#432;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7917;a
&#273;&#7901;i phân b&#7889;: 45 phút.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7917;a
&#273;&#7901;i th&#7843;i tr&#7915;: C&#7911;a daunorubicin: 18,5 gi&#7901;, c&#7911;a
các ch&#7845;t chuy&#7875;n hóa: 55 gi&#7901;, c&#7911;a daunorubicinol: 26,7
gi&#7901;. Do v&#7853;y, t&#7891;n t&#7841;i lâu trong máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7843;i
tr&#7915;: Kéo dài, 25% th&#7843;i tr&#7915; &#7903; d&#7841;ng ho&#7841;t tính
qua n&#432;&#7899;c ti&#7875;u, kho&#7843;ng 40% &#273;&#432;&#7907;c th&#7843;i
tr&#7915; qua m&#7853;t.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh trong &#273;i&#7873;u tr&#7883;
b&#7879;nh b&#7841;ch c&#7847;u c&#7845;p th&#7875; t&#7911;y và th&#7875;
lymphô.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Không
dùng cho ng&#432;&#7901;i m&#7899;i m&#7855;c ho&#7863;c &#273;ang m&#7855;c b&#7879;nh
th&#7911;y &#273;&#7853;u ho&#7863;c zona.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Không
dùng &#273;&#432;&#7901;ng tiêm b&#7855;p và tiêm d&#432;&#7899;i da.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
ph&#7843;i &#273;&#432;&#7907;c dùng r&#7845;t th&#7853;n tr&#7885;ng, d&#432;&#7899;i
s&#7921; theo dõi c&#7911;a bác s&#297; chuyên khoa có kinh nghi&#7879;m v&#7873;
hóa tr&#7883; li&#7879;u ch&#7889;ng ung th&#432;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;c
tính ch&#7911; y&#7871;u c&#7911;a daunorubicin là &#7913;c ch&#7871; t&#7911;y
x&#432;&#417;ng, &#273;&#7863;c bi&#7879;t có th&#7875; n&#7863;ng v&#7899;i
dòng b&#7841;ch c&#7847;u h&#7841;t nh&#432;ng tác d&#7909;ng ít h&#417;n
&#273;&#7871;n ti&#7875;u c&#7847;u và h&#7891;ng c&#7847;u. C&#7847;n ki&#7875;m
tra công th&#7913;c máu c&#7849;n th&#7853;n. Nh&#7919;ng ng&#432;&#7901;i b&#7879;nh
nhi&#7877;m HIV ph&#7843;i &#273;&#432;&#7907;c theo dõi c&#7849;n th&#7853;n
&#273;&#7875; phát hi&#7879;n các bi&#7875;u hi&#7879;n c&#7911;a nhi&#7877;m
trùng c&#417; h&#7897;i ho&#7863;c gian phát.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7843;i
chú ý &#273;&#7863;c bi&#7879;t &#273;&#7871;n ti&#7873;m n&#259;ng &#273;&#7897;c
tính tim c&#7911;a daunorubicin, &#273;&#7863;c bi&#7879;t &#7903; ng&#432;&#7901;i
b&#7879;nh tr&#432;&#7899;c &#273;ây &#273;ã dùng anthracyclin, ho&#7863;c
ng&#432;&#7901;i &#273;ã m&#7855;c b&#7879;nh tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
c&#361;ng &#273;ã gây ho&#7841;i t&#7917; mô t&#7841;i ch&#7895; thu&#7889;c b&#7883;
thoát m&#7841;ch, do &#273;ó s&#7917; d&#7909;ng thu&#7889;c ph&#7843;i c&#7849;n
th&#7853;n &#273;&#7875; &#273;&#7843;m b&#7843;o thu&#7889;c không b&#7883;
thoát m&#7841;ch.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>C&#7847;n
gi&#7843;m li&#7873;u &#7903; ng&#432;&#7901;i b&#7879;nh suy gan ho&#7863;c
suy th&#7853;n.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
có th&#7875; nên tránh dùng các thu&#7889;c ch&#7889;ng ung th&#432;, &#273;&#7863;c
bi&#7879;t trong th&#7901;i gian 3 tháng &#273;&#7847;u c&#7911;a thai k&#7923;.
M&#7863;c dù thông tin còn ch&#432;a th&#7853;t &#273;&#7847;y &#273;&#7911; do
t&#432;&#417;ng &#273;&#7889;i ít tr&#432;&#7901;ng h&#7907;p dùng thu&#7889;c
ch&#7889;ng ung th&#432; khi mang thai, nên ph&#7843;i chú ý &#273;&#7871;n kh&#7843;
n&#259;ng gây &#273;&#7897;t bi&#7871;n và gây ung th&#432; c&#7911;a các thu&#7889;c
lo&#7841;i này. Nh&#7919;ng nguy c&#417; khác &#273;&#7889;i v&#7899;i thai nhi
bao g&#7891;m các tác d&#7909;ng ph&#7909; g&#7863;p &#7903; ng&#432;&#7901;i l&#7899;n.
Nói chung nên dùng thu&#7889;c tránh thai trong khi s&#7917; d&#7909;ng các thu&#7889;c
&#273;&#7897;c h&#7841;i t&#7871; bào.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#432;a
bi&#7871;t thu&#7889;c có bài ti&#7871;t qua s&#7919;a m&#7865; hay không,
nh&#432;ng do kh&#7843; n&#259;ng thu&#7889;c có tác d&#7909;ng ph&#7909; m&#7841;nh
&#7903; tr&#7867; còn bú, nên bà m&#7865; c&#7847;n ng&#7915;ng cho con bú
trong th&#7901;i kì dùng daunorubicin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt;1/100</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>&#7912;c
ch&#7871; t&#7911;y x&#432;&#417;ng, gi&#7843;m b&#7841;ch c&#7847;u, suy t&#7911;y
x&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
letter-spacing:.1pt'>Viêm mi&#7879;ng, r&#7909;ng tóc, viêm t&#297;nh m&#7841;ch,
s&#7889;t, thi&#7871;u máu, bu&#7891;n nôn, nôn, viêm niêm m&#7841;c, &#7881;a
ch&#7843;y, ban &#273;&#7887;, n&#432;&#7899;c ti&#7875;u có th&#7875; &#273;&#7887;
t&#7841;m th&#7901;i sau &#273;i&#7873;u tr&#7883; b&#7857;ng daunorubicin</span><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hi&#7871;m
g&#7863;p, ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7883;
&#7913;ng (ban &#273;&#7887; da và ng&#7913;a), &#273;&#7897;c cho tim &#7903;
d&#7841;ng viêm c&#417; tim, viêm màng ngoài tim.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng
d&#7851;n cách x&#7917; trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng
ph&#7909; gây &#7913;c ch&#7871; t&#7911;y x&#432;&#417;ng c&#7911;a thu&#7889;c
c&#7847;n ph&#7843;i &#273;&#432;&#7907;c ng&#259;n ch&#7863;n tr&#432;&#7899;c
&#7903; m&#7885;i tr&#432;&#7901;ng h&#7907;p b&#7857;ng cách &#273;i&#7873;u
tr&#7883; nhi&#7877;m khu&#7849;n tr&#432;&#7899;c khi dùng daunorubicin, cách
ly ng&#432;&#7901;i b&#7879;nh và &#273;i&#7873;u tr&#7883; h&#7895; tr&#7907;,
k&#7875; c&#7843; s&#7917; d&#7909;ng ti&#7871;p t&#7909;c thu&#7889;c ch&#7889;ng
nhi&#7877;m khu&#7849;n, dùng huy&#7871;t t&#432;&#417;ng giàu ti&#7875;u c&#7847;u,
ho&#7863;c truy&#7873;n máu t&#432;&#417;i toàn ph&#7847;n và m&#7897;t s&#7889;
tr&#432;&#7901;ng h&#7907;p truy&#7873;n b&#7841;ch c&#7847;u.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
dùng và cách dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
r&#7845;t kích &#7913;ng v&#7899;i các mô, nên ch&#7881; &#273;&#432;&#7907;c
dùng &#273;&#432;&#7901;ng t&#297;nh m&#7841;ch. L&#432;&#7907;ng thu&#7889;c
20 mg b&#7897;t &#273;&#7875; pha tiêm trong l&#7885; th&#432;&#7901;ng
&#273;&#432;&#7907;c pha v&#7899;i 4 ml n&#432;&#7899;c c&#7845;t tiêm &#273;&#7875;
có dung d&#7883;ch n&#7891;ng &#273;&#7897; 5 mg/ml. Khi pha l&#7855;c m&#7841;nh
cho thu&#7889;c tan h&#7871;t. L&#7845;y l&#432;&#7907;ng thu&#7889;c &#273;&#7883;nh
dùng vào 1 b&#417;m tiêm có ch&#7913;a t&#7915; 10 - 15 ml dung d&#7883;ch tiêm
natri clorid 0,9% r&#7891;i tiêm ch&#7853;m 2 - 3 phút vào dây truy&#7873;n ho&#7863;c
m&#7841;ch nhánh c&#7911;a &#273;&#432;&#7901;ng truy&#7873;n t&#297;nh m&#7841;ch
dung d&#7883;ch natri clorid 0,9% ho&#7863;c dextrose 5% cho ch&#7843;y t&#7921;
do không hãm. C&#7847;n theo dõi c&#7849;n th&#7853;n v&#7883; trí truy&#7873;n
và vùng xung quanh &#273;&#7875; phát hi&#7879;n thu&#7889;c thoát m&#7841;ch
và kích &#7913;ng t&#297;nh m&#7841;ch.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
c&#361;ng &#273;&#432;&#7907;c pha trong 100 ml dung d&#7883;ch tiêm natri
clorid 0,9% ho&#7863;c dextrose 5% r&#7891;i truy&#7873;n trong 30 - 45 phút.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
ng&#432;&#7901;i l&#7899;n: </span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>40 - 60 mg/m<sup>2</sup>/ngày, m&#7897;t
&#273;&#7907;t &#273;i&#7873;u tr&#7883; bình th&#432;&#7901;ng 3 l&#7847;n
tiêm.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7879;nh
b&#7841;ch c&#7847;u th&#7875; t&#7911;y c&#7845;p: 45 mg/m<sup>2</sup>/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7879;nh
b&#7841;ch c&#7847;u th&#7875; lymphô c&#7845;p: 45 mg/m<sup>2</sup>/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
tr&#7867; em:</span></i><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'> Trên 2 tu&#7893;i: gi&#7889;ng nh&#432; ng&#432;&#7901;i
l&#7899;n; d&#432;&#7899;i <br>
2 tu&#7893;i: ho&#7863;c di&#7879;n tích da d&#432;&#7899;i 0,5 m<sup>2</sup>:
1 mg/kg/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
cao tu&#7893;i:</span></i><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'> Daunorubicin &#273;&#432;&#7907;c dùng th&#7853;n tr&#7885;ng
&#7903; ng&#432;&#7901;i có d&#7921; tr&#7919; t&#7911;y x&#432;&#417;ng không
&#273;&#7911; do tu&#7893;i già, c&#7847;n gi&#7843;m li&#7873;u t&#7899;i 50%.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>S&#7889;
l&#7847;n tiêm dao &#273;&#7897;ng r&#7845;t r&#7897;ng gi&#7919;a các ng&#432;&#7901;i
b&#7879;nh và ph&#7843;i &#273;&#432;&#7907;c xác &#273;&#7883;nh tùy t&#7915;ng
tr&#432;&#7901;ng h&#7907;p c&#7909; th&#7875;, phù h&#7907;p v&#7899;i s&#7921;
&#273;áp &#7913;ng và dung n&#7841;p thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Daunorubicin
ph&#7843;i &#273;&#432;&#7907;c truy&#7873;n vào t&#297;nh m&#7841;ch l&#7899;n
và cho ch&#7843;y t&#7921; do. Khi tiêm truy&#7873;n l&#7847;n 2 ho&#7863;c các
l&#7847;n ti&#7871;p theo, li&#7873;u dùng và kho&#7843;ng cách truy&#7873;n
tùy thu&#7897;c vào tác d&#7909;ng c&#7911;a li&#7873;u dùng tr&#432;&#7899;c
&#273;ó và ph&#7843;i cân nh&#7855;c r&#7845;t th&#7853;n tr&#7885;ng, ph&#7843;i
ki&#7875;m tra máu ngo&#7841;i vi, và trong m&#7897;t s&#7889; tr&#432;&#7901;ng
h&#7907;p, ph&#7843;i ki&#7875;m tra t&#7911;y x&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
letter-spacing:.1pt'>Ph&#7843;i gi&#7843;m li&#7873;u dùng &#7903; ng&#432;&#7901;i
suy gan, suy th&#7853;n. Li&#7873;u dùng c&#7847;n gi&#7843;m 25% &#7903;
ng&#432;&#7901;i có n&#7891;ng &#273;&#7897; bilirubin huy&#7871;t thanh là 20
- 50 micromol/lít ho&#7863;c creatinin máu là 105 - 265 micromol/lít. &#7903;
ng&#432;&#7901;i b&#7879;nh có n&#7891;ng &#273;&#7897; biliburin huy&#7871;t
thanh trên 50 micromol/lít ho&#7863;c creatinin trên 265 micromol/lít, c&#7847;n
gi&#7843;m li&#7873;u dùng 50%.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7883;ch
&#273;&#7853;m &#273;&#7863;c daunorubicin citrat &#7903; d&#7841;ng vi h&#7841;t
lipid ph&#7843;i &#273;&#432;&#7907;c pha loãng 1:1 v&#7899;i dung d&#7883;ch
tiêm dextrose 5% (không dùng dung d&#7883;ch natri clorid 0,9%, ho&#7863;c các
ch&#7845;t kìm khu&#7849;n nh&#432; c&#7891;n benzylic ho&#7863;c b&#7845;t k&#7923;
m&#7897;t dung d&#7883;ch nào khác), &#273;&#7875; có m&#7897;t dung d&#7883;ch
1 mg/ml và &#273;&#432;&#7907;c truy&#7873;n t&#297;nh m&#7841;ch ch&#7853;m
trong 60 phút.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7889;i
h&#7907;p s&#7917; d&#7909;ng daunorubicin v&#7899;i các thu&#7889;c d&#432;&#7899;i
&#273;ây có th&#7875; gây t&#432;&#417;ng tác: Allopurinol, colchicin,
probenecid, ho&#7863;c sulfinpyrazon: daunorubicin có th&#7875; gây t&#259;ng n&#7891;ng
&#273;&#7897; acid uric trong máu. C&#7847;n &#273;i&#7873;u ch&#7881;nh li&#7873;u
c&#7911;a các thu&#7889;c ch&#7889;ng gút &#273;&#7875; ki&#7875;m soát
t&#259;ng acid uric máu và b&#7879;nh gút. Dùng allopurinol &#273;&#7875; phòng
ng&#7915;a ho&#7863;c &#273;&#7843;o ng&#432;&#7907;c tác d&#7909;ng t&#259;ng
acid uric máu do daunorubicin có th&#7875; t&#7889;t h&#417;n là các thu&#7889;c
gây t&#259;ng bài xu&#7845;t acid uric, vì chúng t&#7841;o nguy c&#417; gây b&#7879;nh
th&#7853;n do acid uric.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Các thu&#7889;c
gây lo&#7841;n t&#7841;o máu:</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Tác d&#7909;ng gây gi&#7843;m b&#7841;ch
c&#7847;u, gi&#7843;m ti&#7875;u c&#7847;u c&#7911;a daunorubicin t&#259;ng lên
khi dùng &#273;&#7891;ng th&#7901;i v&#7899;i các thu&#7889;c có tác d&#7909;ng
t&#432;&#417;ng t&#7921;. Ði&#7873;u ch&#7881;nh li&#7873;u daunorubicin n&#7871;u
c&#7847;n, d&#7921;a vào công th&#7913;c máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Các thu&#7889;c
&#7913;c ch&#7871; t&#7911;y x&#432;&#417;ng ho&#7863;c chi&#7871;u x&#7841;:</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> S&#7869;
làm t&#259;ng &#7913;c ch&#7871; t&#7911;y x&#432;&#417;ng, khi dùng cùng ho&#7863;c
ti&#7871;p nhau, c&#7847;n gi&#7843;m li&#7873;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cyclophosphamid
ho&#7863;c chi&#7871;u x&#7841; vào vùng trung th&#7845;t</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Dùng
&#273;&#7891;ng th&#7901;i v&#7899;i daunorubicin có th&#7875; gây t&#259;ng
&#273;&#7897;c v&#7899;i tim. T&#7893;ng li&#7873;u daunorubicin &#273;&#432;&#7907;c
khuy&#7871;n cáo không v&#432;&#7907;t quá 400 mg/m<sup>2</sup> di&#7879;n tích
c&#417; th&#7875;, khi dùng &#273;&#7891;ng th&#7901;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Doxorubicin:
Dùng daunorubicin &#7903; ng&#432;&#7901;i b&#7879;nh tr&#432;&#7899;c &#273;ó
&#273;ã dùng doxorubicin s&#7869; t&#259;ng nguy c&#417; &#273;&#7897;c v&#7899;i
tim, c&#7847;n ph&#7843;i gi&#7843;m li&#7873;u. Không nên dùng daunorubicin &#7903;
ng&#432;&#7901;i tr&#432;&#7899;c &#273;ây &#273;ã &#273;&#432;&#7907;c &#273;i&#7873;u
tr&#7883; doxorubicin ho&#7863;c daunorubicin v&#7899;i t&#7893;ng li&#7873;u
&#273;&#7847;y &#273;&#7911;. &#7903; ng&#432;&#7901;i b&#7879;nh tr&#432;&#7899;c
&#273;ây ch&#432;a dùng &#273;&#7911; t&#7893;ng li&#7873;u doxorubicin, t&#7893;ng
li&#7873;u tích t&#7909; c&#7911;a doxorubicin và daunorubicin không
&#273;&#432;&#7907;c v&#432;&#7907;t quá 550 mg/m<sup>2</sup> c&#417; th&#7875;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Các thu&#7889;c
&#273;&#7897;c v&#7899;i gan khác: </span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Dùng &#273;&#7891;ng th&#7901;i v&#7899;i
daunorubicin gây nguy c&#417; ng&#7897; &#273;&#7897;c, ví d&#7909;: li&#7873;u
cao methotrexat có th&#7875; gây suy ch&#7913;c n&#259;ng gan và t&#259;ng
&#273;&#7897;c tính c&#7911;a daunorubicin n&#7871;u dùng daunorubicin ti&#7871;p
sau methotrexat.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Các
vaccin virus s&#7889;ng:</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Vì c&#417; ch&#7871; t&#7921; b&#7843;o
v&#7879; c&#7911;a c&#417; th&#7875; có th&#7875; b&#7883; gi&#7843;m do dùng
daunorubicin nên n&#7871;u dùng &#273;&#7891;ng th&#7901;i có th&#7875; làm
t&#259;ng kh&#7843; n&#259;ng nhân lên c&#7911;a virus vaccin, làm t&#259;ng
tác d&#7909;ng ph&#7909;, gi&#7843;m &#273;áp &#7913;ng kháng th&#7875;. Vi&#7879;c
tiêm ch&#7911;ng &#7903; các ng&#432;&#7901;i b&#7879;nh này ch&#7881; có th&#7875;
&#273;&#432;&#7907;c th&#7921;c hi&#7879;n khi &#273;ã có s&#7921; ki&#7875;m
soát r&#7845;t ch&#7863;t ch&#7869; công th&#7913;c máu và &#273;&#432;&#7907;c
bác s&#297; chuyên khoa có kinh nghi&#7879;m s&#7917; d&#7909;ng daunorubicin
&#273;&#7891;ng ý.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7843;o
qu&#7843;n b&#7897;t pha tiêm (l&#7885;) &#7903; nhi&#7879;t &#273;&#7897;
phòng và tránh ánh sáng. Sau khi pha thành dung d&#7883;ch, ph&#7843;i dùng
ngay, ho&#7863;c dùng trong vòng 24 gi&#7901;, n&#7871;u &#273;&#432;&#7907;c b&#7843;o
qu&#7843;n &#7903; 2 - 8<sup>o</sup>C, tránh ánh sáng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7843;o
qu&#7843;n d&#7883;ch &#273;&#7853;m &#273;&#7863;c &#7903; d&#7841;ng vi h&#7841;t
lipid &#7903; 2 - 8<sup>0</sup>C, tránh ánh sáng và không &#273;&#432;&#7907;c
&#273;&#7875; &#273;ông b&#259;ng. D&#7883;ch &#273;ã pha loãng &#273;&#7875;
truy&#7873;n t&#297;nh m&#7841;ch ph&#7843;i dùng ngay ho&#7863;c b&#7843;o qu&#7843;n
&#7903; 2 - 8<sup>0</sup>C trong t&#7889;i &#273;a 6 gi&#7901;.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
k&#7925;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Gentamicin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá
li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Các tri&#7879;u
ch&#7913;ng quá li&#7873;u bao g&#7891;m suy t&#7911;y (&#273;&#7863;c bi&#7879;t
là gi&#7843;m b&#7841;ch c&#7847;u h&#7841;t), y&#7871;u m&#7879;t, bu&#7891;n
nôn, nôn.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>C&#7847;n
&#273;i&#7873;u tr&#7883; h&#7895; tr&#7907;. Hình nh&#432; hi&#7879;u qu&#7843;
&#273;i&#7873;u tr&#7883; và &#273;&#7897;c tính không thay &#273;&#7893;i b&#7903;i
th&#7849;m phân màng b&#7909;ng và l&#7885;c th&#7853;n nhân t&#7841;o quy
&#432;&#7899;c.<o:p></o:p></span></p>

<p class=cach0 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Daunorubicin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
</html>
